Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement

被引：55
|
作者：
Saito, K [1 ]
Nawata, M [1 ]
Nakayamada, S [1 ]
Tokunaga, M [1 ]
Tsukada, J [1 ]
Tanaka, Y [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源：
LUPUS | 2003年 / 12卷 / 10期
关键词：
D O I：
10.1191/0961203303lu450xx
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：798 / 800
页数：3
相关论文
共 50 条
  • [31] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
    Albert, D
    Khan, S
    Stansberry, J
    Kolasinski, S
    Tsai, D
    Kamoun, M
    Eisenberg, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S446 - S447
  • [32] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
    Albert, DA
    Khan, SR
    Stansberry, J
    Tsai, D
    Eisenberg, RA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3659 - 3659
  • [33] Anti-CD20 monoclonal antibody (Rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement
    Hänel, M
    Fiedler, F
    Thorns, C
    ONKOLOGIE, 2001, 24 (05): : 491 - 494
  • [34] A Rapidly Progressive, Life-Threatening Postpartum Hemorrhage Successful Treatment With Anti-CD-20 Monoclonal Antibody
    Mei-Dan, Elad
    Walfisch, Asnat
    Martinowitz, Uri
    Hallak, Mordechai
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (02) : 417 - 419
  • [35] Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): Five cases
    Antonucci, Angela
    Negosanti, Massimino
    Tabanelli, Michela
    Varotti, Claudio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (03) : 178 - 183
  • [36] Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab
    Kordelas, Lambros
    Trenschel, Rudolf
    Koldehoff, Michael
    Elmaagacli, Ahmet
    Beelen, Dietrich W.
    ONKOLOGIE, 2008, 31 (12): : 691 - 693
  • [37] Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab
    Swords, R
    Nolan, A
    Fay, M
    Quinn, J
    O'Donnell, R
    Murphy, PT
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 57 - 59
  • [38] Treatment of thrombocytopenia in refractory Evan's syndrome with anti-CD20 monoclonal antibody (Rituximab).
    Baltathakis, I
    Kakkas, I
    Karkatitaris, C
    Papasavvas, PL
    Tsionos, K
    BLOOD, 2002, 100 (11) : 82B - 82B
  • [39] Severe idiopathic erythroblastic synartesis: successful treatment with the anti-CD20 monoclonal antibody rituximab
    Papakonstantinou, Georgios
    Loeffler, Helmut
    Haferlach, Torsten
    Brugger, Wolfram
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) : 547 - 549
  • [40] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
12345